JOHNSON & JOHNSON is 17.9x more valuable than BeOne Medicines AG by market capitalization ($574.10 B vs $32.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ONC | JNJ |
|---|---|---|
| Market cap | $32.14 B | $574.10 B |
| US-listed rank | #444 | #20 |
| Revenue (latest FY) | $5.34B | $94.19B |
| Net income (latest FY) | $286.93M | $26.80B |
| Net margin | 5.4% | 28.5% |
| P/E (trailing FY) | 112.0 | 21.4 |
| SEC filings | 1,167 | 984 |
JOHNSON & JOHNSON is 17.9x more valuable than BeOne Medicines AG by market capitalization ($574.10 B vs $32.14 B).
In their latest fiscal years, BeOne Medicines AG reported $5.34B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: BeOne Medicines AG and JOHNSON & JOHNSON, or browse the full rankings.